The Biotech Influencer Series Part 2: Anu Acharya

The Biotech Influencer Series Part 2: Anu Acharya

This post is part of our Biotech Influencer series in which leading experts share their take on the state of the industry, top trends to watch, and what the future holds.

The following is an interview with Anu Acharya, CEO of MapmyGenome India.

How Has the Biotech Industry Evolved in the Past 5 Years?

The Biotech industry has seen some of its greatest changes in the past 5 years. The most impactful developments include:

• Genomic data has become affordable and accessible to consumers by companies like MapmyGenome

• The continued evolution of new techniques like CRISPR that are truly life-changing

• Technology like machine learning and artificial intelligence have invaded the world of biotech, bringing both positive and potentially challenging uses

• Enhancing life/longevity research with the use of genomics and other technologies like telomeres and microbiomes has made massive strides

What Are the Top Biotech Technology Trends You’re Seeing?

• Advances in gene editing technologies such as CAR-T and CRISPR-CAS9 can spur major changes in cancer treatment and in preventing diseases such as cystic fibrosis

• Big data, AR/VR visualisation improvements, and blockchain technologies are building a scope for secure, patient-centric collaborative platforms for genomics and precision medicine

• Adoption of artificial intelligence in the pharma industry with focus on improving efficacy and safety of treatment options increases the relevance of pharmacogenomic data

• As costs come down and regulatory approvals for personalised drugs go up, genomic data will become the foundational data layer for most drug development and diagnostics

• CRISPR: massive implications for every human must be considered if ethical and moral borders are crossed

• Consumers creating and owning their own data

Read the full interview on Disruptor Daily →